首页 | 本学科首页   官方微博 | 高级检索  
检索        

DNA甲基转移酶1在胰腺癌组织中的表达及其临床意义
引用本文:张尤历,徐岷,高道键,张玉琦,高军,杜奕奇,龚燕芳,满晓华,李兆申.DNA甲基转移酶1在胰腺癌组织中的表达及其临床意义[J].中华胰腺病杂志,2010,10(6).
作者姓名:张尤历  徐岷  高道键  张玉琦  高军  杜奕奇  龚燕芳  满晓华  李兆申
作者单位:1. 江苏大学附属医院消化科,江苏镇江,212001
2. 第二军医大学长海医院消化科
基金项目:江苏省自然科学基金,江苏省卫生厅科研项目,镇江市科研计划项目
摘    要:目的 探讨DNA甲基转移酶1(DNMT1)在胰腺癌组织中的表达及其临床意义.方法 收集手术切除的30例胰腺癌组织和配对癌旁组织.采用实时定量PCR法检测DNMT1 mRNA的表达;免疫组织化学法检测DNMT1蛋白的表达;分析胰腺癌组织DNMT1蛋白表达强度与临床病理参数之间的关系.结果 胰腺癌组织中DNMT1 mRNA的表达量为2.32(1.17~5.17),显著高于配对癌旁组织的0.78(0.07~3.14,P<0.05).胰腺癌组织中导管细胞DNMT1蛋白表达阳性率为(54.5±21.2)%,显著高于癌旁组织(10.9±15.0)%的表达阳性率(P<0.01).以胰腺癌导管细胞DNMT1阳性率54.5%为界,分为高表达组(19例)和低表达组(11例).DNMT1表达强度和临床分期(x2=6.897,P=0.029)、淋巴结转移(x2=4.739,P=0.029)、神经浸润与否(x2=5.44,P=0.020)相关,而与年龄、性别、肿瘤位置、肿瘤大小、肿瘤分化、血清CEA和CA19-9浓度无关.结论 胰腺癌组织DNMT1 mRNA和蛋白表达明显增加,DNMT1蛋白表达强度与胰腺癌的侵袭力、淋巴结转移和神经浸润相关.

关 键 词:胰腺肿瘤  DNA甲基转移酶1(DNMT1)  免疫组织化学

Expressions and clinical significance of DNA methyltransferase 1 in pancreatic carcinoma
Authors:ZHANG You-li  XU Min  GAO Dao-jian  ZHANG Yu-qi  GAO Jun  DU Yi-qi  GONG Yan-fang  MAN Xiao-hua  LI Zhao-shen
Abstract:Objective To investigate the expressions of DNA methyltransferase 1 (DNMT1) in pancreatic carcinoma and its clinical significance.Methods 30 samples of pancreatic cancer tissues and paired para-cancerous tissues were collected from patients who underwent curative pancreatectomy.The levels of DNMT1 mRNA were detected by real-time RT-PCR.Expressions of DNMT1 protein were detected by streptavidin peroxidase immunohistochemistry.The relationships between expression of DNMT1 and clinicopathological findings were analyzed.Results The value of relative quantification (RQ) of DNMT1 mRNA in human pancreatic cancer tissues was 2.32 (1.17 ~ 5.17 ), which was significant higher than 0.78 (0.07 ~3.14) in para-cancerous tissues(P <0.05).The index of expression of DNMT1 protein in human pancreatic cancer tissues was (54.5 ±21.2)% ,which was significant higher than( 10.9 ± 15.0)% in paracancerous tissues (P < 0.01 ).Patients were divided into the high DNMT1 group (n = 19) with above 54.5% of the DNMT1 positively cancer cells and the low DNMT1 group ( n = 11 ) with less than 54.5% of the DNMT1 positively cancer cells.The high expression of DNMT1 was correlated significantly with clinical staging ( x2 =6.897, P = 0.029), lymph node metastasis ( x2 = 4.739, P = 0.029) and neural invasion ( x2 = 5.44, P =0.020).On the other hand, no association between DNMT1 expression and age, gender, tumor location,tumor size, tumor differentiation, the serum CEA and CA19-9 levels could be found.Conclusions DNMT1 mRNA and protein was highly expressed in pancreatic cancer tissues.High expression of DNMT1 might be related to the aggressiveness of pancreatic cancer, lymph node metastasis and neural invasion.
Keywords:Pancreatic neoplasms  DNA methyhransferase 1 ( DNMT1 )  Immunohistochemistry
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号